Synthetic host molecules and sequestrants as therapeutic agents

Drug Discovery Today: Technologies

Volumn 7, Issue 2, 2010, Pages

  Zhang, Ming Qiang ^a  

^a Roche RandD Center China Ltd   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; AGENTS AFFECTING METABOLISM; ANTIBIOTIC AGENT; ANTIDOTE; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ATROPINE; BILE ACID SEQUESTRANT; COLESEVELAM; COLESTIPOL; COLESTYRAMINE; DEFEROXAMINE; DIGOXIN; DIGOXIN ANTIBODY F(AB) FRAGMENT; DIGOXINDICARBOXYMETHOXYLAMINE; EZETIMIBE; GFB 111; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; ION EXCHANGE RESIN; MIGLUSTAT; MUSCLE RELAXANT AGENT; NEOSTIGMINE; ROCURONIUM; SPERMINE DERIVATIVE; SUGAMMADEX; SUXAMETHONIUM; TELAVANCIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ATHEROSCLEROSIS; BACTERIAL INFECTION; BINDING AFFINITY; CHEMICAL STRUCTURE; CHOLESTEROL METABOLISM; CONSTIPATION; DRUG APPROVAL; DRUG DESIGN; DRUG DETOXIFICATION; DRUG SYNTHESIS; DRUG TARGETING; GAUCHER DISEASE; GRAM POSITIVE INFECTION; HEMOCHROMATOSIS; HOMEOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; INBORN ERROR OF METABOLISM; INFECTIOUS DIARRHEA; IRON CHELATION; IRON OVERLOAD; LIPID STORAGE; LOSS OF FUNCTION MUTATION; METABOLIC DISORDER; NEOPLASM; NEUROMUSCULAR BLOCKING; NIEMANN PICK DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATIENT COMPLIANCE; PROTEIN PROTEIN INTERACTION; REVIEW; SINGLE DRUG DOSE; SKIN INFECTION; SUPRAMOLECULAR CHEMISTRY;

EID: 78650753070     PISSN: 17406749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddtec.2010.07.002     Document Type: Review

References (19)

1. S. Bradberry, and A. Vale A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning Clin. Toxicol. (Phila.) 47 2009 841 858
2. T. Manning Iron chelators in medicinal applications - chemical equilibrium considerations in pharmaceutical activity Curr. Med. Chem. 16 2009 2416 2429
3. M-Q. Zhang Drug-specific cyclodextrins: the future of rapid neuromuscular block reversal? Drugs Future 28 2003 347 354
4. J.M. Adam Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationships J. Med. Chem. 45 2002 1806 1816
5. R.M. Hogg, and R.K. Mirakhur Sugammadex: a selective relaxant binding agent for reversal of neuromuscular block Expert Rev. Neurother. 9 2009 599 608
6. L.P. Yang, and S.J. Keam Sugammadex: a review of its use in anaesthetic practice Drugs 69 2009 919 942
7. Y. Nitanai Crystal structures of the complexes between vancomycin and cell-wall precursor analogs J. Mol. Biol. 385 2009 1422 1432
8. C.S. Lunde Telavancin disrupts the functional integrity of the bacterial membrane through targeted interaction with the cell wall precursor lipid II Antimicrob. Agents Chemother. 53 2009 3375 3383
9. J. Scheiring Clinical practice. Today's understanding of the haemolytic uraemic syndrome Eur. J. Pediatr. 169 2010 7 13
10. L.S. Simpson Selective toxin sequestrants for the treatment of bacterial infections J. Am. Chem. Soc. 131 2009 5760 5762
11. R.G. Zhang The three-dimensional crystal structure of cholera toxin J. Mol. Biol. 251 1995 563 573
12. Y. Tang Niemann-Pick disease type C: from molecule to clinic Clin. Exp. Pharmacol. Physiol. 37 2010 132 140
13. -/- mouse Proc. Natl. Acad. Sci. U. S. A. 106 2009 2377 2382
14. A.I. Rosenbaum Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cells Proc. Natl. Acad. Sci. U. S. A. 2010 early edition (http://www.pnas.org/cgi/doi/10.1073/pnas. 0914309107 )
15. H.E. Bays, and R.B. Goldberg The 'forgotten' bile acid sequestrants: is now a good time to remember? Am. J. Ther. 14 2007 567 580
16. R. Amendola Spermine metabolism and anticancer therapy Curr. Cancer Drug Targets 9 2009 118 130
17. L. Vial Controlling the biological effects of spermine using a synthetic receptor J. Am. Chem. Soc. 128 2006 10253 10257
18. S.M. Sebti, and A.D. Hamilton Design of growth factor antagonists with antiangiogenic and antitumor properties Oncogene 19 2000 6566 6573
19. J. Sun Inhibiting angiogenesis and tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to their receptors Oncogene 24 2005 4701 4709